These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34118726)

  • 1. MUC1 regulates AKT signaling pathway by upregulating EGFR expression in ovarian cancer cells.
    Ma Q; Song J; Wang S; He N
    Pathol Res Pract; 2021 Aug; 224():153509. PubMed ID: 34118726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC1 induces the accumulation of Foxp3
    Zhang G; Zheng G; Zhang H; Qiu L
    Int Immunopharmacol; 2023 May; 118():110091. PubMed ID: 37018979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
    Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
    J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
    Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
    Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmocollin 3 mediates follicle stimulating hormone-induced ovarian epithelial cancer cell proliferation by activating the EGFR/Akt signaling pathway.
    Yang X; Wang J; Li WP; Jin ZJ; Liu XJ
    Int J Clin Exp Pathol; 2015; 8(6):6716-23. PubMed ID: 26261554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner.
    Jin W; Liao X; Lv Y; Pang Z; Wang Y; Li Q; Liao Y; Ye Q; Chen G; Zhao K; Huang L
    Cell Death Dis; 2017 Aug; 8(8):e2980. PubMed ID: 28796259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling.
    Zhang X; Qin T; Zhu Z; Hong F; Xu Y; Zhang X; Xu X; Ma A
    Am J Med Sci; 2020 Feb; 359(2):123-129. PubMed ID: 32039764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
    Zhang L; Liu XL; Yuan Z; Cui J; Zhang H
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4663-4672. PubMed ID: 31210292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182.
    Zong ZH; Du YP; Guan X; Chen S; Zhao Y
    J Exp Clin Cancer Res; 2019 Oct; 38(1):437. PubMed ID: 31666098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC1 stimulates EGFR expression and function in endometrial cancer.
    Engel BJ; Bowser JL; Broaddus RR; Carson DD
    Oncotarget; 2016 May; 7(22):32796-809. PubMed ID: 27092881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway.
    Woo JK; Choi Y; Oh SH; Jeong JH; Choi DH; Seo HS; Kim CW
    Oncogene; 2012 Apr; 31(17):2187-98. PubMed ID: 21927028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway.
    Shen F; Zong ZH; Liu Y; Chen S; Sheng XJ; Zhao Y
    Biomed Pharmacother; 2019 Jun; 114():108787. PubMed ID: 30925458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway.
    Guo J; Schally AV; Zarandi M; Varga J; Leung PC
    Reprod Biol Endocrinol; 2010 May; 8():54. PubMed ID: 20509930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the oncogenic MUC1-C protein inhibits mutant EGFR-mediated signaling and survival in non-small cell lung cancer cells.
    Kharbanda A; Rajabi H; Jin C; Tchaicha J; Kikuchi E; Wong KK; Kufe D
    Clin Cancer Res; 2014 Nov; 20(21):5423-34. PubMed ID: 25189483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
    Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L
    PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB.
    Zhang Z; Zhang L; Wang B; Wei R; Wang Y; Wan J; Zhang C; Zhao L; Zhu X; Zhang Y; Chu C; Guo Q; Yin X; Li X
    Cancer Lett; 2020 Jan; 469():54-67. PubMed ID: 31629932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of MED12 Induces Tumor Dormancy in Human Epithelial Ovarian Cancer via Downregulation of EGFR.
    Luo XL; Deng CC; Su XD; Wang F; Chen Z; Wu XP; Liang SB; Liu JH; Fu LW
    Cancer Res; 2018 Jul; 78(13):3532-3543. PubMed ID: 29735544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.